Tenax Therapeutics To Provide Corporate Update And Discuss Second Quarter Fiscal Year 2016 Financial Results On December 15, 2015

MORRISVILLE, N.C.--(BUSINESS WIRE)--Tenax Therapeutics, Inc. (NASDAQ: TENX), a specialty pharmaceutical company focused on identifying, developing and commercializing products for the critical care market, today announced that the Company will host a conference call and live audio webcast on Tuesday, December 15, 2015, at 8:30 a.m. ET to provide a corporate update and discuss financial results for the second quarter fiscal year 2016 ended October 31, 2015.